CO2016005763A1 - Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxide - Google Patents

Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxide

Info

Publication number
CO2016005763A1
CO2016005763A1 CONC2016/0005763A CO2016005763A CO2016005763A1 CO 2016005763 A1 CO2016005763 A1 CO 2016005763A1 CO 2016005763 A CO2016005763 A CO 2016005763A CO 2016005763 A1 CO2016005763 A1 CO 2016005763A1
Authority
CO
Colombia
Prior art keywords
ultraviolet
cerium oxide
nanoparticulate
radiation
mineral composition
Prior art date
Application number
CONC2016/0005763A
Other languages
Spanish (es)
Inventor
Luna Alina Lucia Imbeth
Quintero John Jairo Zuluaga
Original Assignee
Pure Chemistry S A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pure Chemistry S A S filed Critical Pure Chemistry S A S
Priority to CONC2016/0005763A priority Critical patent/CO2016005763A1/en
Publication of CO2016005763A1 publication Critical patent/CO2016005763A1/en

Links

Landscapes

  • Cosmetics (AREA)

Abstract

La presente solicitud se relaciona con formulaciones para el cuidado o la protección de la piel contra la radiación ultravioleta, las cuales tienen como ingrediente principal óxido de cerio no nanoparticulado que no dejan residuos visibles sobre la piel, en otras palabras no se genera un tono blancuzco causado por la presencia de óxidos como el de cinc o el de titanio; donde la composición de acuerdo con la presente invención, comprende óxido de cerio que no ha sido tratado hasta reducir su tamaño de partícula a una escala manométrica y el óxido de cerio no es nanoparticulado antes de ser incorporado a la formulación, sino que forma una emulsión cuya composición presenta una estructura que corresponde a cristales líquidos.The present application relates to formulations for the care or protection of the skin against ultraviolet radiation, which have as its main ingredient non-nanoparticulate cerium oxide that does not leave visible residues on the skin, in other words a whitish tone is not generated caused by the presence of oxides such as zinc or titanium; wherein the composition according to the present invention comprises cerium oxide that has not been treated until its particle size is reduced to a manometric scale and cerium oxide is not nanoparticulate before being incorporated into the formulation, but forms an emulsion whose composition has a structure that corresponds to liquid crystals.

CONC2016/0005763A 2016-12-26 2016-12-26 Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxide CO2016005763A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CONC2016/0005763A CO2016005763A1 (en) 2016-12-26 2016-12-26 Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CONC2016/0005763A CO2016005763A1 (en) 2016-12-26 2016-12-26 Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxide

Publications (1)

Publication Number Publication Date
CO2016005763A1 true CO2016005763A1 (en) 2018-01-05

Family

ID=62596888

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2016/0005763A CO2016005763A1 (en) 2016-12-26 2016-12-26 Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxide

Country Status (1)

Country Link
CO (1) CO2016005763A1 (en)

Similar Documents

Publication Publication Date Title
CL2019003264A1 (en) Formulations for vaccines against neoplasia and methods for preparing the same. (divisional request 201703151)
CY1124592T1 (en) 3-PHENYLISOXAZOLINE-5-CARBOXAMIDES HERBICIDIC ACTIVE FORMULATED FROM TETRAHYDRO- AND DIHYDROFURANCARBOXYLIC ACIDS AND ESTERS
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
BR122021018243A8 (en) LOW PH TOPICAL COMPOSITION AND METHOD TO INCREASE THE TOPICAL APPLICATION OF A COSMETICALLY ACCEPTABLE ACTIVE INGREDIENT
CL2016002276A1 (en) Topical compositions comprising an extract of coriolus versicolor to increase autoimmunity
WO2016007629A3 (en) Compositions and delivery methods for treating dental infections, inflammation, sensitivity, and for use in dental restorations
BR112018005905A2 (en) ? compound, pharmaceutical composition, methods to prevent or treat a disease or condition, organ damage, hepatotoxicity and fatty liver, and, use of a compound?
BR112016004358A8 (en) pharmaceutical combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases, pharmaceutical composition, their uses, and kit
EA201590730A1 (en) METHOD AND STEROID COMPOSITION FOR LOCAL APPLICATION
CL2019003572A1 (en) Low-dose brimonidine combinations and uses thereof.
CL2015002513A1 (en) Acellular vaccine against pertussis
CL2016001019A1 (en) Compositions and procedures for the treatment of dental hypersensitivity
PH12018502110A1 (en) A cosmetic composition
MX2022001404A (en) Liquid dressing compositions and their veterinary uses.
AR101581A1 (en) COLUTORY COMPOSITION
ES2895910T3 (en) Multiphase compositions
SA521420975B1 (en) Nanostructured Formulations for The Delivery of Silibinin and Other Active Ingredients for Treating Ocular Diseases
BR112015021640A2 (en) photoprotective personal care composition, method for providing enhanced skin spf and use of a
MX2018005786A (en) Novel formulations.
ES2514140B1 (en) Use of the STX64 steroid sulfatase inhibitor for the treatment of aging
CO2016005763A1 (en) Mineral composition attenuator of ultraviolet a, ultraviolet b and ultraviolet c radiation, based on non-nanoparticulate cerium oxide
CL2020001738A1 (en) Percutaneous absorption preparation for the treatment of dementia containing donepezil.
CL2020000551A1 (en) Formulation for topical use for the control and prevention of parasites in animals.
CL2021001655A1 (en) Antimicrobial compositions comprising modified clay and biphenol.
SV2016005308A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALOPATHIES RELATED TO PAIN, USING AS ACTIVE AGENT TO KETOROLACO TROMETAMINE AND TRAMADOL CHLORHYDRATE